Cellosaurus logo
expasy logo

Cellosaurus TGW (CVCL_1771)

[Text version]
Cell line name TGW
Synonyms TOG; TGW-nu; TGW-I-nu; TGW-nu-1
Accession CVCL_1771
Resource Identification Initiative To cite this cell line use: TGW (RRID:CVCL_1771)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Population: Japanese.
Doubling time: 32 hours (Note=Lot 06012007), ~27 hours (Note=Lot 04172014) (JCRB=JCRB0618).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Array-based CGH.
Omics: CRISPR phenotypic screen.
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
Genome ancestry Source: PubMed=30894373

Origin% genome
African0
Native American0
East Asian, North71.87
East Asian, South26.74
South Asian0.97
European, North0.42
European, South0
Disease Adrenal gland neuroblastoma (NCIt: C4827)
Neuroblastoma (ORDO: Orphanet_635)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_3180 (TGW.P3)CVCL_A443 (TNB1)
Sex of cell Male
Age at sampling 1Y11M
Category Cancer cell line
STR profile Source(s): Cosmic-CLP=910780; DepMap=ACH-001674; JCRB=JCRB0618

Markers:
AmelogeninX
CSF1PO15
D3S135816
D5S81813
D7S82012
D8S117914
D13S3178,11
D16S5399,13
D18S5114
D21S1130,33.2
FGA23
Penta D9,10
Penta E11,12
TH016,7
TPOX10,11
vWA14,18

Run an STR similarity search on this cell line
Web pages https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-424.html
Publications

PubMed=2335222; DOI=10.1016/0014-5793(90)81370-4
Tsuchida Y., Sekiguchi M., Kaneko Y., Kanda N.
Origin of human neuroblastoma cell lines TGW and TNB1.
FEBS Lett. 263:191-191(1990)

PubMed=12210830; DOI=10.1002/jnr.10330
Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.
Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
J. Neurosci. Res. 69:642-652(2002)

PubMed=15892104; DOI=10.1002/gcc.20198
Mosse Y.P., Greshock J., Margolin A.A., Naylor T., Cole K.A., Khazi D., Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L., Maris J.M.
High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.
Genes Chromosomes Cancer 43:390-403(2005)

PubMed=18923524; DOI=10.1038/nature07399
Chen Y.-Y., Takita J., Choi Y.L., Kato M., Ohira M., Sanada M., Wang L.-L., Soda M., Kikuchi A., Igarashi T., Nakagawara A., Hayashi Y., Mano H., Ogawa S.
Oncogenic mutations of ALK kinase in neuroblastoma.
Nature 455:971-974(2008)

PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113
Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=30971826; DOI=10.1038/s41586-019-1103-9
Behan F.M., Iorio F., Picco G., Goncalves E., Beaver C.M., Migliardi G., Santos R., Rao Y., Sassi F., Pinnelli M., Ansari R., Harper S., Jackson D.A., McRae R., Pooley R., Wilkinson P., van der Meer D.J., Dow D., Buser-Doepner C.A., Bertotti A., Trusolino L., Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature 568:511-516(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line collections (Providers) JCRB; JCRB0618
Cell line databases/resources CLO; CLO_0009830
cancercelllines; CVCL_1771
Cell_Model_Passport; SIDM00324
Cosmic-CLP; 910780
DepMap; ACH-001674
LINCS_LDP; LCL-1962
Lonza; 1191
Biological sample resources BioSample; SAMN03471635
CRISP screens repositories BioGRID_ORCS_Cell_line; 1037
Chemistry resources ChEMBL-Cells; CHEMBL3308792
ChEMBL-Targets; CHEMBL1075600
GDSC; 910780
PharmacoDB; TGW_1592_2019
PubChem_Cell_line; CVCL_1771
Encyclopedic resources Wikidata; Q54972266
Experimental variables resources EFO; EFO_0022441
Gene expression databases ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-3610
GEO; GSM314028
GEO; GSM333815
GEO; GSM1670542
Polymorphism and mutation databases Cosmic; 801749
Cosmic; 910780
Cosmic; 920238
Cosmic; 947703
Cosmic; 1037349
Cosmic; 1099146
Cosmic; 1153801
Cosmic; 2131589
Progenetix; CVCL_1771
Proteomic databases PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
Entry history
Entry creation04-Apr-2012
Last entry update10-Sep-2024
Version number38